Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
Automated Clinical Protocol Design Market Forecasts to 2032 – Global Analysis By Component (Algorithmic Decision Engines, Workflow Automation Modules, Clinical Knowledge Libraries, Data Integration Interfaces, Validation & Compliance Checkers and Simulation & Scenario Modelling Tools), Deployment Mode, Application, End User, and By Geography.
US$ 4,150.00
According to Stratistics MRC, the Global Automated Clinical Protocol Design Market is accounted for $1.8 billion in 2025 and is expected to reach $6.5 billion by 2032 growing at a CAGR of 20.1% during...
November 2025
200 pages
Drug Repurposing Market Forecasts to 2032 – Global Analysis By Therapeutic Area (Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Autoimmune & Inflammatory Diseases, Rare Diseases, Metabolic Disorders, and Other Therapeutic Areas), Drug Type, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Drug Repurposing Market is accounted for $0.46 billion in 2025 and is expected to reach $1.40 billion by 2032 growing at a CAGR of 17.0% during the forecast pe...
November 2025
200 pages
Hormone-Balancing Therapeutics Market Forecasts to 2032 – Global Analysis By Hormone Type (Estrogen Modulators, Testosterone Regulators, Thyroid Hormone Therapies, Cortisol Balancing Drugs, Insulin & Metabolic Hormones and Peptide-Based Hormone Therapies), Formulation, Technology, Application, End User, and By Geography.
US$ 4,150.00
According to Stratistics MRC, the Global Hormone-Balancing Therapeutics Market is accounted for $23.6 billion in 2025 and is expected to reach $39.4 billion by 2032 growing at a CAGR of 7.6% during th...
November 2025
200 pages
Hyperkalemia Drugs Market Forecasts to 2032 – Global Analysis By Drug Type (Sodium Polystyrene Sulfonate (SPS), Patiromer, Sodium Zirconium Cyclosilicate, Calcium Polystyrene Sulfonate, and Other Drug Types), Route of Administration, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Hyperkalemia Drugs Market is accounted for $1.42 billion in 2025 and is expected to reach $3.97 billion by 2032 growing at a CAGR of 15.8% during the forecast...
November 2025
200 pages
Sinusitis Drugs Market Forecasts to 2032 – Global Analysis By Drug Class (Antibiotics, Combination Therapies, Intranasal Corticosteroids, Biologics & Monoclonal Antibodies, Oral Corticosteroids, Mucolytics & Expectorants, Antihistamines, Decongestants, Saline Solutions & Irrigation Products, and Other Drug Classes), Route of Administration, Disease Type, Prescription Type, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Sinusitis Drugs Market is accounted for $3.11 billion in 2025 and is expected to reach $4.96 billion by 2032 growing at a CAGR of 6.9% during the forecast peri...
November 2025
200 pages
Pharmaceutical Filtration: Global Markets
US$ 4,650.00
: The global market for pharmaceutical filtration is expected to grow from $12 billion in 2025 and is projected to reach $20.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of...
November 2025
152 pages
Active Pharmaceutical Ingredients CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Molecule Type (Small Molecule, Large Molecule), By Synthesis (Biotech, Synthetic), By Drug Type (Innovative, Generics), By Workflow (Clinical, Commercial), By Application (Cardiology, Oncology, Ophthalmology, Neurology, Orthopedic, Other), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Active Pharmaceutical Ingredients CDMO Market, valued at USD 96.98 Million in 2024, is projected to experience a CAGR of 6.10% to reach USD 138.35 Million by 2030. An Active Pharmaceutical...
November 2025
185 pages
Albumin Excipient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Human Serum Albumin, Recombinant Albumin), By End user (Pharmaceutical And Biotechnology Industry, Research Institutes, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Albumin Excipient Market, valued at USD 4.98 Billion in 2024, is projected to experience a CAGR of 8.01% to reach USD 7.91 Billion by 2030. Albumin excipient is a highly purified protein, t...
November 2025
187 pages
Antiviral Combination Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Branded, Generic), By Drug Combination (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels), By Indications (Human Immunodeficiency Virus, Hepatitis, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Antiviral Combination Therapy Market, valued at USD 52.72 Billion in 2024, is projected to experience a CAGR of 6.85% to reach USD 78.46 Billion by 2030. Antiviral combination therapy invol...
November 2025
187 pages
Asthma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Anti-inflammatory, Combination Therapy, Bronchodilators), By Product (Inhalers (Dry powder inhalers, Metered dose inhalers, Soft mist inhalers), Nebulizers), By Route of Administration (Oral, Inhaled, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Asthma Therapeutics Market will grow from USD 27.52 Billion in 2024 to USD 34.3 Billion by 2030 at a 3.74% CAGR. Asthma therapeutics encompass a range of pharmaceutical medications and trea...
November 2025
185 pages
Myasthenia Gravis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Cholinesterase Inhibitors, Chronic Immunomodulators, Monoclonal Antibodies, Rapid Immunotherapies, Thymectomy, Others), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), Region and Competition, 2020-2030F
US$ 4,500.00
The Global Myasthenia Gravis Treatment Market, valued at USD 2.32 Billion in 2024, is projected to experience a CAGR of 7.44% to reach USD 3.57 Billion by 2030. Myasthenia Gravis treatment encompasses...
November 2025
185 pages
Softgel Capsules Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Gelatin-Based/Animal-Based, Non-Animal-Based), By Application (Antacid and Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplement, Vitamin and Dietary Supplement, Pregnancy, Others), End Use (Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organization), By Region, and Competition, 2020-2030F
US$ 4,500.00
The Global Softgel Capsules Market, valued at USD 8.02 Billion in 2024, is projected to experience a CAGR of 7.86% to reach USD 12.63 Billion by 2030. Softgel capsules represent a specialized oral dos...
November 2025
182 pages
Gout Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (NSAIDs, Colchicine, Urate-lowering Drugs, Biologics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, By Competition 2020-2030F
US$ 4,500.00
The Global Gout Therapeutics Market, valued at USD 2.16 Billion in 2024, is projected to experience a CAGR of 8.80% to reach USD 3.58 Billion by 2030. Gout therapeutics comprise pharmaceutical interve...
November 2025
180 pages
Hepatology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Antiviral Drugs, Vaccines, Immunosuppressants, Targeted Therapy, Chemotherapy, Corticosteroids, Immunoglobulins), By Disease Type (Hepatitis, Liver Cancer, Genetic Disorders, Autoimmune Diseases, Non- Alcoholic Fatty Liver Diseases, Others) Region and Competition, 2020-2030F
US$ 4,500.00
The Global Hepatology Market, valued at USD 12.18 Billion in 2024, is projected to experience a CAGR of 8.60% to reach USD 19.98 Billion by 2030. The global hepatology market encompasses the study, pr...
November 2025
183 pages
Pharmacokinetics Services Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Small Molecules, Large Molecules), By Application (Small and Medium Enterprise, Large Enterprise), By End-use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, others), by region, and Competition, 2020-2030F
US$ 4,500.00
The Global Pharmacokinetics Services Market, valued at USD 1074.36 Million in 2024, is projected to experience a CAGR of 8.20% to reach USD 1723.91 Million by 2030. Pharmacokinetics (PK) services enco...
November 2025
182 pages
Compounding Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas), By Route of Administration (Oral, Topical, Parenteral, Other Route of Administrations), By End User (Humans, Veterinary) By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Compounding Pharmacy Market, valued at USD 12.98 Billion in 2024, is projected to experience a CAGR of 6.52% to reach USD 18.96 Billion by 2030. The global compounding pharmacy market encom...
November 2025
183 pages
Real-World Evidence Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Claims Data, Clinical Settings Data, Patient-Powered Data, Pharmacy Data, Other Components), By Therapeutic Area (Oncology, Immunology, Neurology, Cardiovascular Disease, Other Therapeutic Areas) Region and Competition, 2020-2030F
US$ 4,500.00
The Global Real-World Evidence Solutions Market , valued at USD 2.98 Billion in 2024, is projected to experience a CAGR of 8.99% to reach USD 5.00 Billion by 2030. The Global Real-World Evidence (RWE)...
November 2025
183 pages
Hemoglobinopathies Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Thalassemia, Sickle Cell Disease, Other Hemoglobin (Hb) Variants), By Diagnosis (Blood Test, Genetic Test, Prenatal Genetic Test, Pre-implantation Genetic Diagnosis, Electrophoresis, Others), By Therapy (Blood Transfusion, Iron Chelation Therapy, Hydroxyurea, Bone Marrow Transplant, Others), By Region, Competition, 2020-2030F
US$ 4,500.00
The Global Hemoglobinopathies Market , valued at USD 8.44 Billion in 2024, is projected to experience a CAGR of 12.70% to reach USD 17.29 Billion by 2030. Hemoglobinopathies represent a group of inher...
November 2025
180 pages
